Favorable treatment outcome with neutralizing anti-transforming growth factor β antibodies in experimental diabetic kidney disease

Peritoneal Dialysis International

Volumn 19, Issue SUPPL. 2, 1999, Pages

  Han, Dong Cheol ^a   Ziyadeh, Fuad N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Diabetic nephropathy; Fibrosis; Glomerulosclerosis; Glucose; Mesangium

Indexed keywords

ARACHIDONIC ACID; CYTOKINE; DIACYLGLYCEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSAMINE; GLUCOSE; GROWTH FACTOR; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C; THROMBOXANE; TRANSFORMING GROWTH FACTOR BETA;

BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CELL CULTURE; CELL GROWTH; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DISEASE COURSE; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCATION; HUMAN; HYPERTROPHY; KIDNEY CELL; KIDNEY DISEASE; KIDNEY FUNCTION; METABOLISM; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HUMANS; HYPERTROPHY; KIDNEY; MICE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033402030     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest. 1984; 74:1143-55.
2. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 1981; 19:410-15.
3. The Diabetes Control and Complications Trial Research Group. The effects of intensive insulin treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977-86.
4. Parving H, Andersen A, Smidt U, Svendsen P. Early aggressive anti-hypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet. 1983; ii:1175-9.
5. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993; 329: 1456-62.
6. Ayo SH, Radnik RA, Garoni JA, Glass WF II, Kreisberg JI. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol. 1990; 136:1339-48.
7. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol. 1990; 259:F704-14.
8. Ziyadeh FN. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis. 1993; 22:736-44.
9. Ziyadeh FN. Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease. Miner Electrolyte Metab. 1995; 21:292-302.
10. Rocco M, Chen Y, Goldfarb S, Ziyadeh FN. Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int. 1992; 41:107-14.
11. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN. High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int. 1992; 42:647-56.
12. Sharma K, Ziyadeh FN. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol. 1997; 17:80-92.
13. Wolf G, Ziyadeh F. The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms. Am J Kidney Dis. 1997; 29:153-63.
14. Ziyadeh FN, Han DC, Cohen JA, Guo J, Cohen MP. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: Involvement of the transforming growth factor-β system. Kidney Int. 1998; 53:631-8.
15. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL. Characterization of protein kinase C β-isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest. 1997; 100:115-26.
16. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED. High glucose-induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest. 1998; 101:160-9.
17. Di Paolo S, Gesualdo L, Ranieri E, Grandaliano G, Schena FP. High glucose concentration induces the overexpression of transforming growth factor-β through the activation of a platelet-derived growth factor loop in human mesangial cells. Am J Pathol. 1996; 149:2095-106.
18. Phillips AO, Steadman R, Topley N, Williams JD. Elevated D-glucose concentrations modulate TGF-beta 1 synthesis by human cultured renal proximal tubular cells. The permissive role of platelet-derived growth factor. Am J Pathol. 1995; 147:362-74.
19. Studer RK, Negrete H, Craven PA, DeRubertis FR. Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-beta bioactivity in mesangial cells. Kidney Int. 1995; 48:422-30.
20. Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator. Diabetes. 1995; 44:1139-46.
21. Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, et al. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes. 1993; 42:450-6.
22. Sharma K, Ziyadeh FN. Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol. 1994; 267:F1094-101.
23. Shankland SJ, Scholey JW. Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int. 1994; 46:430-42.
24. Pankewycz OG, Guan JX, Bolton WK, Gomez A, Benedict JF. Renal TGF-beta regulation in spontaneously diabetic NOD mice with correlations in mesangial cells. Kidney Int. 1994; 46:748-58.
25. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA. 1993; 90: 1814-18.
26. Iwano M, Atsushi K, Nishino T, Sato H, Nishioka H, Akai Y, et al. Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus. Kidney Int. 1996; 49:1120-6.
27. Sharma K, Ziyadeh FN, Alzahabi B, McGowan TA, Kapoor S, Kurnik BRC, et al. Increased renal production of transforming growth factor-β 1 in patients with type II diabetes. Diabetes. 1997; 46:854-9.
28. van Det NF, Verhagen NAM, Tamsma JT, Berden JHM, Bruijn JA, Daha MR, et al. Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-β by high glucose, not by angiotensin II. Diabetes. 1997; 46:834-40.
29. Han DC, Hoffman BB, Ziyadeh FN. High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: Mediation by autocrine activation of TGF-β [Abstract]. J Am Soc Nephrol. 1997; 8:516A.
30. Ziyadeh FN, Sharma K, Ericksen M, Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-β. J Clin Invest. 1994; 93:536-42.
31. Kolm V, Sauer U, Olgemoller B, Schleicher ED. High glucose-induced TGF-β 1 regulates mesangial production of heparan sulfate proteoglycan. Am J Physiol. 1996;270:F812-21.
32. Sharma K, Guo J, Jin Y, Ziyadeh FN. Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes. 1996; 45:522-30.
33. Hoffman BB, Han DC, Guo J, Ziyadeh FN. Treatment with antisense TGF-β1 oligodeoxynucleotide diminishes kidney hypertrophy and matrix mRNA levels in diabetic mice [Abstract]. J Am Soc Nephrol. 1998; 9:632A.
34. Ziyadeh FN, Hoffman BB, Guo J, Eltayeb BO, Han DC, Sharma K. Amelioration of renal insufficiency and excess matrix gene expression by chronic treatment with anti-TGF-β antibody in db/db mice [Abstract]. J Am Soc Nephrol. 1998; 9:646A.
35. Terrell TG, Working PK, Chow CP, Green JD. Pathology of recombinant human transforming growth factor-β1 in rats and rabbits. Int Rev Exp Pathol. 1993; 34B:43-67.
36. Isaka Y, Fuijiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest. 1993; 92:2597-601.
37. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest. 1996; 74:991-1003.
38. Clouthier DE, Comerford SA, Hammer RE. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. J Clin Invest. 1997; 100:2697-713.
39. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, et al. Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int. 1996; 49:461-9.
40. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, et al. Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest. 1993; 68:154-63.
41. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes. 1992; 41:1520-7.
42. Lucas C, Bald L, Fendly BM, Mora-Worms M, Figari I, Patzer E, et al. The autocrine production of transforming growth factor-β during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J Immunol. 1990; 145:1415-22.